Fig. 3From: Assessing the value of bypassing agent therapy used prophylactic versus on-demand, during immune tolerance induction for treatment of inhibitors: a retrospective chart reviewResource utilisation in terms of inpatient stays and hospitalisations prior to inhibitor and during ITI by BPA therapy cohorts. ITI ((Immune Tolerance Induction), BPA (Bypass Agent), BPA Px (Bypass Agent Prophylaxis), BPA OD (Bypass Agent On-Demand)Back to article page